Moberg Pharma AB (publ)
At a glance
Most recent filing on May 22, 2026 — an open-market purchase by Lars Johansson on May 22, 2026.
We hold 16 visible filings, going back to May 17, 2019.
Filings we could not classify with confidence are set aside for review, so they are in none of these counts.
Insider trades
What is a MAR filing?5 of 16 shown
- Lars Johansson Chair of the board106,900 SEKOpen-market buy
- Mark Beveridge Chief financial officer321,583 SEKGrant
- Anna Helena Constance Ljung Chief executive officer321,583 SEKGrant
- Annika Christine Magnusson Other member of the administrative, management or supervisory body321,583 SEKGrant
- Annika Christine Magnusson Other member of the administrative, management or supervisory body674,099 SEKGrant
Short positions
All short positionsNet short positions of 0.5% or more in Moberg Pharma AB (publ) that are open today, as the regulator publishes them. Together they come to 0.83% of the shares. Positions below 0.5% are not published, so the real total can be higher.
1 open position, together 0.83%. The holders and their history are part of the subscription.
Källa: Finansinspektionen, October 31, 2026.